ADORA1 and obesity due to melanocortin 4 receptor deficiency: Specific inhibition of ADORA1 in the liver helps prevent body weight gain and alleviate hepatic steatosis, suggesting that ADORA1 might be a promising drug target for treating diabetes and obesity (Hong et al., 2019).